Distinct Patterns of HBV Integration and TERT Alterations between in Tumor and Non-Tumor Tissue in Patients with Hepatocellular Carcinoma
Authors:
- Jeong-Won JangJeong-Won Jang
- Hye-Seon KimHKHye-Seon Kim
- Jin-Seoub KimJKJin-Seoub Kim
- Soon-Kyu LeeSLSoon-Kyu Lee
- Ji-Won HanJHJi-Won Han
- Pil-Soo SungPSPil-Soo Sung
- Si-Hyun BaeSBSi-Hyun Bae
- Jong-Young ChoiJCJong-Young Choi
- Seung-Kew YoonSYSeung-Kew Yoon
- Dong-Jin HanDHDong-Jin Han
- Tae-Min KimTKTae-Min Kim
- Lewis R. RobertsLRLewis R. Roberts
Open Access
- 30 June 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (13) , 7056
Abstract
Although hepatitis B virus (HBV) integration into the cellular genome is well known in HCC (hepatocellular carcinoma) patients, its biological role still remains uncertain. This study investigated the patterns of HBV integration and correlated them with TERT (telomerase reverse transcriptase) alterations in paired tumor and non-tumor tissues. Compared to those in non-tumors, tumoral integrations occurred less frequently but with higher read counts and were more preferentially observed in genic regions with significant enrichment of integration into promoters. In HBV-related tumors, TERT promoter was identified as the most frequent site (38.5% (10/26)) of HBV integration. TERT promoter mutation was observed only in tumors (24.2% (8/33)), but not in non-tumors. Only 3.00% (34/1133) of HBV integration sites were shared between tumors and non-tumors. Within the HBV genome, HBV breakpoints were distributed preferentially in the 3’ end of HBx, with more tumoral integrations detected in the preS/S region. The major genes that were recurrently affected by HBV integration included TERT and MLL4 for tumors and FN1 for non-tumors. Functional enrichment analysis of tumoral genes with integrations showed enrichment of cancer-associated genes. The patterns and functions of HBV integration are distinct between tumors and non-tumors. Tumoral integration is often enriched into both human-virus regions with oncogenic regulatory function. The characteristic genomic features of HBV integration together with TERT alteration may dysregulate the affected gene function, thereby contributing to hepatocarcinogenesis.Keywords
This publication has 23 references indexed in Scilit:
- TERT promoter mutations: Gatekeeper and driver of hepatocellular carcinomaJournal of Hepatology, 2014
- Genetics of hepatocellular carcinoma: The next generationJournal of Hepatology, 2014
- Deep sequencing of the hepatitis B virus in hepatocellular carcinoma patients reveals enriched integration events, structural alterations and sequence variationsCarcinogenesis, 2012
- Genome-wide survey of recurrent HBV integration in hepatocellular carcinomaNature Genetics, 2012
- Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulatorsNature Genetics, 2012
- The role of hepatitis B virus integrations in the pathogenesis of human hepatocellular carcinomaJournal of Hepatology, 2005
- Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase geneOncogene, 2003
- Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancersOncogene, 2003
- Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC)Seminars in Cancer Biology, 2000
- Integration of hepatitis B virus sequences and their expression in a human hepatoma cellNature, 1980